Evaluation of cytokines as adjuvants of infectious bovine keratoconjunctivitis vaccines

被引:9
|
作者
di Girolamo, Fabio A. [1 ,2 ,3 ,4 ]
Jorge Sabatini, Diego [4 ]
Fasan, Raul A. [4 ]
Echegoyen, Maia [4 ]
Vela, Mauro [4 ]
Pereira, Claudio A. [2 ,3 ]
Maure, Pablo [1 ]
机构
[1] CIV, Buenos Aires, DF, Argentina
[2] Consejo Nacl Invest Cient & Tecn, Inst Invest Med A Lanari IDIM, RA-1033 Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Buenos Aires, DF, Argentina
[4] Pontificia Univ Catolica Argentina UCA, Fac Ciencias Agr, Buenos Aires, DF, Argentina
关键词
Infectious bovine keratoconjunctivitis; Moraxella bovis; Cytokines; MORAXELLA-BOVIS; INTERFERON;
D O I
10.1016/j.vetimm.2011.12.022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this work two cytokines were used in combination with inactivated bacteria (bacterin) to test the bovine conjuctival immune response to the pathogen Moraxella bovis, the causative agent of Infectious bovine keratoconjunctivitis (IBK). Treatments using the bacterin vaccine combined with interleukin-2 and interferon-alpha as adjuvants (Group A), the bacterin vaccine only (Group B), and controls without treatment (Group C), were applied by ocular spraying to evaluate the local immune response in the corneal structure of cattle experimentally infected with M. bovis. Six weeks after infection, 14 out of a total of 34 animals presented different corneal lesions; 9 corresponding to the control group C, 4 to the group B and only one to the group A. According to the clinical manifestations, a numeric score was calculated. Control animals presented the highest score value (12 points), followed by group B (7.5 points) and group A (1 point). These results suggest that the addition of cytokines to M. bovis treatments can reduce not only eye injuries caused by IBK but also the number of diseased animals. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:563 / 566
页数:4
相关论文
共 50 条